US4163108A
(en)
*
|
1967-02-16 |
1979-07-31 |
Lever Brothers Company |
Prostaglandins
|
US4054736A
(en)
*
|
1970-06-10 |
1977-10-18 |
Ono Pharmaceutical Co., Ltd. |
Clathrate compounds of prostaglandins or their analogues with cyclodextrin
|
US3903131A
(en)
*
|
1971-04-12 |
1975-09-02 |
Upjohn Co |
16 and 16,16-dimethyl PGE{HD 2{B
|
CA984387A
(en)
*
|
1971-04-12 |
1976-02-24 |
Barney J. Magerlein |
Analogs of prostaglandins
|
US3954833A
(en)
*
|
1971-04-12 |
1976-05-04 |
The Upjohn Company |
16,16-Methyl and ethyl substituted PGF2.sub.α compounds
|
FR2134673A1
(en)
*
|
1971-04-30 |
1972-12-08 |
Ono Pharmaceutical Co |
Novel optically active isomers of prostaglandin analoguesof natural configuration useful as hypotensive agents, diuretics,contraceptives, for treating gastric ulcer and asthma, and forinhibiting platelet aggregation
|
US4045467A
(en)
*
|
1972-02-18 |
1977-08-30 |
May & Baker Limited |
Cyclopentane derivatives
|
US4082789A
(en)
*
|
1972-03-28 |
1978-04-04 |
The University Court Of The University Of Edinburgh |
Prostaglandins C2
|
JPS4926258A
(US07923587-20110412-C00001.png)
*
|
1972-07-06 |
1974-03-08 |
|
|
US4110368A
(en)
*
|
1972-07-24 |
1978-08-29 |
American Cyanamid Company |
Hydro substituted prostanoic acids and esters
|
US4141914A
(en)
*
|
1972-07-24 |
1979-02-27 |
American Cyanamid Company |
Novel 11-deoxy-11-substituted prostaglandins of the E and F series
|
US4130721A
(en)
*
|
1972-07-24 |
1978-12-19 |
The Upjohn Company |
11-Deoxy PGE2 compounds
|
JPS4942648A
(US07923587-20110412-C00001.png)
*
|
1972-08-24 |
1974-04-22 |
|
|
US3962312A
(en)
*
|
1972-09-21 |
1976-06-08 |
Ono Pharmaceutical Company |
9,11,15-Trihydroxy prost-5-enoic acid analogues
|
JPS5443570B2
(US07923587-20110412-C00001.png)
*
|
1972-10-27 |
1979-12-20 |
|
|
US3972917A
(en)
*
|
1972-10-27 |
1976-08-03 |
American Home Products Corporation |
11-Deoxy 15-methyl prostaglandin E1
|
US4092427A
(en)
*
|
1973-04-16 |
1978-05-30 |
American Home Products Corporation |
Method of inducing abortion using alkyl derivatives of prostanoic acids
|
JPS5623984B2
(US07923587-20110412-C00001.png)
*
|
1973-04-19 |
1981-06-03 |
|
|
US4059576A
(en)
*
|
1973-08-06 |
1977-11-22 |
Hoffmann-La Roche, Inc. |
11-Substituted prostaglandins
|
US4246426A
(en)
*
|
1973-08-06 |
1981-01-20 |
Hoffmann-La Roche Inc. |
11-Substituted prostaglandins
|
US4052446A
(en)
*
|
1973-08-06 |
1977-10-04 |
Hoffmann-La Roche Inc. |
11,16-substituted prostaglandins
|
US4026927A
(en)
*
|
1973-09-25 |
1977-05-31 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel prostaglandin derivatives
|
US4036954A
(en)
*
|
1973-11-02 |
1977-07-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Stable prostaglandin E group-containing formulation
|
GB1448268A
(en)
*
|
1973-11-13 |
1976-09-02 |
May & Baker Ltd |
Cyclopentane derivatives
|
GB1441564A
(en)
*
|
1974-02-07 |
1976-07-07 |
Upjohn Co |
Prostaglandins
|
US4041066A
(en)
*
|
1974-02-07 |
1977-08-09 |
The Upjohn Company |
4,5-Cis-didehydro-PGE1 compounds
|
DE2416193C2
(de)
*
|
1974-04-03 |
1985-08-14 |
Hoechst Ag, 6230 Frankfurt |
Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
|
US4256651A
(en)
*
|
1974-10-02 |
1981-03-17 |
The Upjohn Company |
2a,2b-Dihomo-15-alkyl-PGF1β compounds
|
US3974195A
(en)
*
|
1974-10-02 |
1976-08-10 |
The Upjohn Company |
2A,2B-Dihomo-15-alkyl-PGF2.sub.α analogs
|
GB1482010A
(en)
*
|
1974-10-28 |
1977-08-03 |
Ono Pharmaceutical Co |
Prostaglandin analogues
|
DK142235B
(da)
*
|
1974-12-20 |
1980-09-29 |
Yamanouchi Pharma Co Ltd |
Analogifremgangsmåde til fremstilling af 20-alkoxy-16-methyl-prostadiensyre-derivater.
|
US4207420A
(en)
*
|
1975-02-24 |
1980-06-10 |
The Upjohn Company |
2,2-Difluoro-PGF1 analogs
|
US4209637A
(en)
*
|
1975-02-24 |
1980-06-24 |
The Upjohn Company |
2,2-Difluoro-PGF2 analogs
|
US4059701A
(en)
*
|
1975-04-17 |
1977-11-22 |
American Home Products Corporation |
15-Substituted prostanoic acids for treating bronchial spasm
|
FR2313019A2
(fr)
*
|
1975-06-04 |
1976-12-31 |
Ono Pharmaceutical Co |
Nouveaux analogues de prostaglandines et leur procede de preparation
|
US4086269A
(en)
*
|
1975-07-07 |
1978-04-25 |
American Home Products Corporation |
11-Deoxy-15-substituted prostaglandins
|
US4026909A
(en)
*
|
1975-07-14 |
1977-05-31 |
The Upjohn Company |
Cis-13-PGF2.sub.α analogs
|
US4033989A
(en)
*
|
1975-09-17 |
1977-07-05 |
The Upjohn Company |
9-Deoxy-PGF2 Analogs
|
US4016184A
(en)
*
|
1975-09-17 |
1977-04-05 |
The Upjohn Company |
9-Deoxy-9,10-didehydro-PGD1 compounds
|
US4053500A
(en)
*
|
1975-10-02 |
1977-10-11 |
The Upjohn Company |
4,4,5,5-Tetradehydro-ω-aryl-PGF1α analogs
|
US4053502A
(en)
*
|
1975-10-02 |
1977-10-11 |
The Upjohn Company |
4,4,5,5-Tetradehydro-ω-aryl-PGE1 analogs
|
US4013695A
(en)
*
|
1975-10-02 |
1977-03-22 |
The Upjohn Company |
4,4,5,5-Tetradehydro-PGE1 analogs
|
US4026919A
(en)
*
|
1975-10-23 |
1977-05-31 |
The Upjohn Company |
PGD2 Substituted esters
|
US4058665A
(en)
*
|
1975-11-06 |
1977-11-15 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel 3,15-dilower alkyl PGE2 derivatives
|
US4212987A
(en)
*
|
1976-09-17 |
1980-07-15 |
The Upjohn Company |
2,2-Difluoro-PGE1 analogs
|
US4212986A
(en)
*
|
1976-09-17 |
1980-07-15 |
The Upjohn Company |
2,2-Difluoro-PGE2 analogs
|
US4169895A
(en)
*
|
1976-09-28 |
1979-10-02 |
Pfizer Inc. |
Antisecretory 16,16-dimethyl-17-oxaprostaglandins
|
JPS53136513A
(en)
*
|
1977-05-06 |
1978-11-29 |
Ono Pharmaceut Co Ltd |
Stabilization of prostaglandin-x-related compounds
|
HU179141B
(US07923587-20110412-C00001.png)
*
|
1977-09-23 |
1982-08-28 |
|
|
JPS5577440U
(US07923587-20110412-C00001.png)
*
|
1978-11-25 |
1980-05-28 |
|
|
US4244883A
(en)
*
|
1979-09-12 |
1981-01-13 |
The Upjohn Company |
2a,2b-Dihomo-15-alkyl-PGF2β compounds
|
ZA831186B
(en)
*
|
1982-03-22 |
1983-11-30 |
Upjohn Ltd |
Gelled pge2/triacetin solutions
|
DE3504044A1
(de)
*
|
1985-02-04 |
1986-08-07 |
Schering AG, Berlin und Bergkamen, 1000 Berlin |
9-halogenprostaglandin-clathrate und ihre verwendung als arzneimittel
|
DE3608088C2
(de)
*
|
1986-03-07 |
1995-11-16 |
Schering Ag |
Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
|
DE3740838A1
(de)
*
|
1987-11-27 |
1989-06-08 |
Schering Ag |
Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
|
US5221695A
(en)
*
|
1987-12-22 |
1993-06-22 |
Glaxo Group Limited |
Aqueous formulation containing a piperidinylcyclopentylheptenoic acid derivative and beta-cyclodextrin
|
SE502288C2
(sv)
*
|
1987-12-22 |
1995-09-25 |
Glaxo Group Ltd |
Vattenhaltig komposition innehållande ett piperidinylcyklopentylheptenonsyraderivat
|
KR0166088B1
(ko)
*
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
US5376645A
(en)
*
|
1990-01-23 |
1994-12-27 |
University Of Kansas |
Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
|
US5874418A
(en)
*
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
DE19828881A1
(de)
*
|
1998-06-22 |
1999-12-23 |
Schering Ag |
Oxidationsinhibitor bei Prostan-Derivaten
|
US6287603B1
(en)
|
1999-09-16 |
2001-09-11 |
Nestec S.A. |
Cyclodextrin flavor delivery systems
|
HU230421B1
(hu)
|
2001-07-23 |
2016-05-30 |
Ono Pharmaceutical Co., Ltd |
Csonttömegveszteséggel kapcsolatos betegségek kezelésére adható, EP4 agonistát tartalmazó gyógyászati készítmények és hatóanyagként alkalmazható vegyületek
|
EP1563846B1
(en)
|
2002-10-10 |
2012-08-29 |
Ono Pharmaceutical Co., Ltd. |
Endogenous repair factor production promoters
|
EP2422814A1
(en)
|
2003-07-25 |
2012-02-29 |
Ono Pharmaceutical Co., Ltd. |
Remedy for cartilage-related diseases
|
CN100542537C
(zh)
*
|
2004-07-27 |
2009-09-23 |
中国人民解放军军事医学科学院毒物药物研究所 |
前列腺素e1口腔制剂
|
JP2008543831A
(ja)
*
|
2005-06-13 |
2008-12-04 |
カーギル インコーポレイテッド |
シクロデキストリン包接複合体及びその製造方法
|
BRPI0612032A2
(pt)
*
|
2005-06-13 |
2010-10-13 |
Cargill Inc |
complexos de inclusão de ciclodextrina e métodos de preparação dos mesmos
|
JP2009539978A
(ja)
*
|
2006-06-13 |
2009-11-19 |
カーギル インコーポレイテッド |
大粒子シクロデキストリン包接複合体及びその製造方法
|
EP2049083A2
(en)
*
|
2006-12-27 |
2009-04-22 |
Cargill, Incorporated |
Stabilisation by preparing cyclodextrin inclusion complexes
|
EP2123273B1
(en)
|
2007-02-16 |
2013-10-23 |
ONO Pharmaceutical Co., Ltd. |
Therapeutic agent for urinary excretion disorder
|
WO2008136519A1
(ja)
|
2007-05-08 |
2008-11-13 |
National University Corporation, Hamamatsu University School Of Medicine |
Ep4アゴニストを含有してなる細胞傷害性t細胞の活性化剤
|
US20080283693A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Evans Michael J F |
Propulsion apparatus and system
|
PT2441760E
(pt)
|
2009-06-10 |
2014-01-07 |
Ono Pharmaceutical Co |
Composto com actividade de contracção muscular do detrusor e actividade de relaxação muscular do esfíncter uretral
|
JP4890657B1
(ja)
*
|
2011-06-03 |
2012-03-07 |
小野薬品工業株式会社 |
リマプロストとβ−シクロデキストリンを含有する錠剤
|
AU2012290987B2
(en)
|
2011-08-02 |
2017-04-20 |
Ono Pharmaceutical Co., Ltd. |
Left ventricular diastolic function improving agent
|
CA2882732C
(en)
|
2012-08-31 |
2021-03-30 |
Ono Pharmaceutical Co., Ltd. |
A 2-[(2-{(1r,5r)-2-oxo-5-[(1e,4s)-7,8,8-trifluoro-4-hydroxy-4-methyl-1,7-octadiene-1-yl]cyclopentyl}ethyl)thio}-1,3-thiazole-4-carboxylic acid 4-piperidinemethanol salt and crystals thereof
|
ES2890238T3
(es)
|
2016-05-09 |
2022-01-18 |
Agc Inc |
Nuevo derivado de prostaglandina
|
CN117881648A
(zh)
*
|
2021-09-13 |
2024-04-12 |
富士胶片株式会社 |
双环烷烃化合物的包合物的制造方法
|